Table 2. The proportion of individual with different status of disease/SNP1/SNP2 could be calculated by pbaseline, MAF1, MAF2, ORy,SNP1, ORy,SNP2 and ORinteraction.
SNP1 | SNP2 | Disease | Proportion in total population |
---|---|---|---|
Major homozygous | Major homozygous | Control | (1-MAF1)2(1-MAF2)2(1-q1) |
Major homozygous | Major homozygous | Case | (1-MAF1)2(1-MAF2)2q1 |
Major homozygous | Heterogeneous | Control | 2(1-MAF1)2(1-MAF2)p6(1-q2) |
Major homozygous | Heterogeneous | Case | 2(1-MAF1)2(1-MAF2)p6q2 |
Major homozygous | Minor homozygous | Control | (1-MAF1)2(1-MAF2)2(1-q3) |
Major homozygous | Minor homozygous | Case | (1-MAF1)2(1-MAF2)2q3 |
Heterogeneous | Major homozygous | Control | 2MAF1(1-MAF1)(1-MAF2)2(1-q4) |
Heterogeneous | Major homozygous | Case | 2MAF1(1-MAF1)(1-MAF2)2q4 |
Heterogeneous | Heterogeneous | Control | 4MAF1(1-MAF1)(1-MAF2)p6(1-q5) |
Heterogeneous | Heterogeneous | Case | 4MAF1(1-MAF1)(1-MAF2)p6q5 |
Heterogeneous | Minor homozygous | Control | 2MAF1(1-MAF1)(1-MAF2)2(1-q6) |
Heterogeneous | Minor homozygous | Case | 2MAF1(1-MAF1)(1-MAF2)2q6 |
Minor homozygous | Major homozygous | Control | MAF12(1-MAF2)2(1-q7) |
Minor homozygous | Major homozygous | Case | MAF12(1-MAF2)2q7 |
Minor homozygous | Heterogeneous | Control | 2MAF12(1-MAF2)p6(1-q8) |
Minor homozygous | Heterogeneous | Case | 2MAF12(1-MAF2)p6q8 |
Minor homozygous | Minor homozygous | Control | MAF12(1-MAF2)2(1-q9) |
Minor homozygous | Minor homozygous | Case | MAF12(1-MAF2)2q9 |
pbaseline: the disease risk in subjects with major homozygous genotype of SNP1 and SNP2 in each simulated population; MAF1: the minor allele frequency of SNP1; MAF2: the minor allele frequency of SNP2; ORy,SNP1: the main effect of SNP1; ORy,SNP2: the main effect of SNP2; ORinteraction: gene–gene interaction effect between SNP1 and SNP2.
q1 to q9: the disease prevalence of individuals with different genotype.
- q1 = pbaseline = (1 + exp(−ln(pbaseline /(1 − pbaseline))))−1